Company Quick10K Filing
Citizens & Northern
10-Q 2021-03-31 Filed 2021-05-07
10-K 2020-12-31 Filed 2021-03-05
10-Q 2020-09-30 Filed 2020-11-06
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-02-20
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-31 Filed 2019-02-21
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-06
10-Q 2018-03-31 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-02-15
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-08-03
10-Q 2017-03-31 Filed 2017-05-04
10-K 2016-12-31 Filed 2017-02-16
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-18
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-02-26
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-09
10-K 2013-12-31 Filed 2014-02-20
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-02-21
10-Q 2012-09-30 Filed 2012-11-07
10-Q 2012-06-30 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-02-24
10-Q 2011-09-30 Filed 2011-11-07
10-Q 2011-06-30 Filed 2011-08-08
10-Q 2011-03-31 Filed 2011-05-06
10-K 2010-12-31 Filed 2011-03-01
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-01
8-K 2021-01-21 Earnings, Exhibits
8-K 2020-10-22
8-K 2020-07-16
8-K 2020-07-01
8-K 2020-05-07
8-K 2020-04-16
8-K 2020-04-16
8-K 2020-04-02
8-K 2020-02-20
8-K 2020-01-16
8-K 2019-12-18
8-K 2019-10-17
8-K 2019-08-07
8-K 2019-07-18
8-K 2019-07-18
8-K 2019-06-12
8-K 2019-04-18
8-K 2019-04-18
8-K 2019-04-18
8-K 2019-04-01
8-K 2019-03-01
8-K 2019-01-17
8-K 2018-12-20
8-K 2018-10-18
8-K 2018-09-27
8-K 2018-08-24
8-K 2018-08-08
8-K 2018-07-19
8-K 2018-06-11
8-K 2018-04-19
8-K 2018-04-19
8-K 2018-04-19
8-K 2018-01-18

Citizens & Northern Financials

CZNC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash49565752643855403138395554503232312833382430292931303734493637444051
Accounts Receivable
Inventory
PP&E22191919191947181818471717164716161648151515501616154715151547151616
Assets1,3101,3121,3241,3171,3281,3101,2871,2401,2281,2331,2381,2351,2561,2571,2421,2521,2561,2331,2231,2171,2311,2451,2421,2341,2431,2601,2771,2581,2841,2851,2911,2901,6101,643
Accounts Payable
Long-Term Debt13312812511511090847773737373737373736363393939393838383191827333633
Liabilities1,1561,1511,1561,1451,1511,1301,1041,0571,0491,0521,0581,0501,0671,0701,0541,0631,0691,0421,0361,0281,0401,0551,0561,0471,0541,0691,0891,0721,0951,0951,0941,0881,3701,400
Stockholders' Equity179181179185189187188189187190187188191191186187190191188186189190197202240243
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax210310012111111111111211221121111
Net Income6666656555444444444444434424766545
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating510368107118467364654455544666359
Cash Investing10-1361-93728-90-1024-22-7-5-7-9221215-28-9-78-1311-11-161362-18
Cash Financing-84-146-26-30-50-11-27-1414-1-1932-30-11-138101-1216-2020-3-9-7221